175 related articles for article (PubMed ID: 34743946)
21. Attenuation of nociceptive and paclitaxel-induced neuropathic pain by targeting inflammatory, CGRP and substance P signaling using 3-Hydroxyflavone.
Ullah R; Ali G; Subhan F; Naveed M; Khan A; Khan J; Halim SA; Ahmad N; Zakiullah ; Al-Harrasi A
Neurochem Int; 2021 Mar; 144():104981. PubMed ID: 33549629
[TBL] [Abstract][Full Text] [Related]
22. The prophylactic effects of a traditional Japanese medicine, goshajinkigan, on paclitaxel-induced peripheral neuropathy and its mechanism of action.
Matsumura Y; Yokoyama Y; Hirakawa H; Shigeto T; Futagami M; Mizunuma H
Mol Pain; 2014 Sep; 10():61. PubMed ID: 25240613
[TBL] [Abstract][Full Text] [Related]
23. Encapsulating paclitaxel in polymeric nanomicelles increases antitumor activity and prevents peripheral neuropathy.
Oda CMR; Silva JO; Fernandes RS; Braga AV; Machado RR; Coelho MM; Cassali GD; Reis DC; de Barros ALB; Leite EA
Biomed Pharmacother; 2020 Dec; 132():110864. PubMed ID: 33254426
[TBL] [Abstract][Full Text] [Related]
24. Protective Effects of Glatiramer Acetate Against Paclitaxel-Induced Peripheral Neuropathy in Rats: A Role for Inflammatory Cytokines and Oxidative Stress.
Dekamin S; Ghasemi M; Dehpour AR; Ghazi-Khansari M; Shafaroodi H
Neurochem Res; 2024 Apr; 49(4):1049-1060. PubMed ID: 38252396
[TBL] [Abstract][Full Text] [Related]
25. Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment.
Mo M; Erdelyi I; Szigeti-Buck K; Benbow JH; Ehrlich BE
FASEB J; 2012 Nov; 26(11):4696-709. PubMed ID: 22889832
[TBL] [Abstract][Full Text] [Related]
26. Identification of fluocinolone acetonide to prevent paclitaxel-induced peripheral neuropathy.
Cetinkaya-Fisgin A; Joo MG; Ping X; Thakor NV; Ozturk C; Hoke A; Yang IH
J Peripher Nerv Syst; 2016 Sep; 21(3):128-33. PubMed ID: 27117347
[TBL] [Abstract][Full Text] [Related]
27. Involvement of the Sodium Channel Nav1.7 in Paclitaxel-induced Peripheral Neuropathy through ERK1/2 Signaling in Rats.
Wang GJ; Zhang X; Huang LD; Xiao Y
Curr Neurovasc Res; 2020; 17(3):267-274. PubMed ID: 32407275
[TBL] [Abstract][Full Text] [Related]
28. Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.
Naguib M; Xu JJ; Diaz P; Brown DL; Cogdell D; Bie B; Hu J; Craig S; Hittelman WN
Anesth Analg; 2012 May; 114(5):1104-20. PubMed ID: 22392969
[TBL] [Abstract][Full Text] [Related]
29. Effect of Hesperidin on Sciatic Nerve Damage in STZ-Induced Diabetic Neuropathy: Modulation of TRPM2 Channel.
Bayir MH; Yıldızhan K; Altındağ F
Neurotox Res; 2023 Dec; 41(6):638-647. PubMed ID: 37439953
[TBL] [Abstract][Full Text] [Related]
30. Peptidergic intraepidermal nerve fibers in the skin contribute to the neuropathic pain in paclitaxel-induced peripheral neuropathy.
Ko MH; Hu ME; Hsieh YL; Lan CT; Tseng TJ
Neuropeptides; 2014 Jun; 48(3):109-17. PubMed ID: 24630273
[TBL] [Abstract][Full Text] [Related]
31. Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy.
Zhang H; Li Y; de Carvalho-Barbosa M; Kavelaars A; Heijnen CJ; Albrecht PJ; Dougherty PM
J Pain; 2016 Jul; 17(7):775-86. PubMed ID: 26979998
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the effects of berberine on bortezomib-induced sciatic nerve and spinal cord damage in rats through pathways involved in oxidative stress and neuro-inflammation.
Yardim A; Gur C; Comakli S; Ozdemir S; Kucukler S; Celik H; Kandemir FM
Neurotoxicology; 2022 Mar; 89():127-139. PubMed ID: 35121005
[TBL] [Abstract][Full Text] [Related]
33. Neurosteroid 3α-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptoms.
Meyer L; Patte-Mensah C; Taleb O; Mensah-Nyagan AG
PLoS One; 2013; 8(11):e80915. PubMed ID: 24260511
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy.
Griffiths LA; Flatters SJ
J Pain; 2015 Oct; 16(10):981-94. PubMed ID: 26142652
[TBL] [Abstract][Full Text] [Related]
35. Pain Relieving and Neuroprotective Effects of Non-opioid Compound, DDD-028, in the Rat Model of Paclitaxel-Induced Neuropathy.
Micheli L; Rajagopalan R; Lucarini E; Toti A; Parisio C; Carrino D; Pacini A; Ghelardini C; Rajagopalan P; Di Cesare Mannelli L
Neurotherapeutics; 2021 Jul; 18(3):2008-2020. PubMed ID: 34312766
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological interventions targeting Wnt/β-catenin signaling pathway attenuate paclitaxel-induced peripheral neuropathy.
Resham K; Sharma SS
Eur J Pharmacol; 2019 Dec; 864():172714. PubMed ID: 31586636
[TBL] [Abstract][Full Text] [Related]
37. Activation of KCNQ Channels Prevents Paclitaxel-Induced Peripheral Neuropathy and Associated Neuropathic Pain.
Li L; Li J; Zuo Y; Dang D; Frost JA; Yang Q
J Pain; 2019 May; 20(5):528-539. PubMed ID: 30471428
[TBL] [Abstract][Full Text] [Related]
38. Ganglioside GM1 (porcine) ameliorates paclitaxel-induced neuropathy in rats.
Chentanez V; Thanomsridejchai N; Duangmardphon N; Agthong S; Kaewsema A; Huanmanop T; Maneesri S
J Med Assoc Thai; 2009 Jan; 92(1):50-7. PubMed ID: 19260244
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of naringin against oxaliplatin-induced peripheral neuropathy in rats: A behavioral and molecular study.
Semis HS; Kandemir FM; Caglayan C; Kaynar O; Genc A; Arıkan SM
J Biochem Mol Toxicol; 2022 Sep; 36(9):e23121. PubMed ID: 35670529
[TBL] [Abstract][Full Text] [Related]
40. Role of satellite cell-derived L-serine in the dorsal root ganglion in paclitaxel-induced painful peripheral neuropathy.
Kiya T; Kawamata T; Namiki A; Yamakage M
Neuroscience; 2011 Feb; 174():190-9. PubMed ID: 21118710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
